Speciality: Anesthesia
Description:
During surgery, patient safety is the top priority, and continuous monitoring plays a crucial role. Anaesthetists and surgical teams use a range of devices to track vital signs throughout the procedure. Heart rate, blood pressure, and oxygen levels are continuously measured using monitors attached to the patient. An electrocardiogram, or ECG, tracks the heart’s rhythm, while a pulse oximeter measures oxygen saturation in the blood. Capnography is often used to monitor carbon dioxide levels, especially if the patient is under general anaesthesia. These real-time readings allow the team to detect any changes quickly and respond immediately if needed, ensuring patients remain stable and safe at every stage of surgery.
See More Webinars @ Hidoc Webinars
1.
Microplastics can cause malignant changes in lung cells
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
4.
Rural residents continue to have higher odds of skin cancer, study finds
5.
Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer
1.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
2.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
3.
Innovative Approaches in Oncology for Modern Medicine
4.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
5.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Role of Screening in Cancer Prevention
2.
From Guidelines to Practice: Hematology
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation